Apollo Hospitals Q1 Net Profit Rises 34% to ₹5.81 Billion, Beating Estimates

Nikunj Parikh - Mumbai Bureau Aug 12, 2026 3,200 Views

Apollo Hospitals Enterprise Limited reported a 34% increase in Q1 FY27 net profit to ₹5.81 billion, beating analyst estimates. Consolidated revenue from operations rose 21% to ₹70.43 billion, supported by 70% bed occupancy, specialized clinical expansion, and digital healthcare expansion.

CHENNAI, India — Apollo Hospitals Enterprise Limited (AHEL) announced its financial results for the first quarter of fiscal year 2027 on August 12, 2026, outperforming consensus market expectations across key financial indicators.

The healthcare chain reported consolidated revenue from operations of ₹70.43 billion ($70.43 bln rupees), exceeding LSEG IBES estimates of ₹69.06 billion. Consolidated net profit attributable to equity holders reached ₹5.81 billion, surpassing IBES projections of ₹5.62 billion. The growth was anchored by an increase in operational bed occupancy to 70% and expansion across its healthcare services, retail diagnostics, and digital healthcare divisions.

Financial Performance and Earnings Breakdown

Apollo Hospitals' consolidated operations demonstrated steady growth across major financial parameters during Q1 FY27:

Revenue from Operations: Rose 21% year-on-year to ₹70,435 million compared to ₹58,421 million in Q1 FY26.
Net Profit (PAT): Increased 34% year-on-year to ₹5,807 million (attributable to owners) compared to ₹4,328 million in the corresponding quarter last year. Total consolidated PAT stood at ₹6,104 million.
EBITDA: Expanded 28% year-on-year to ₹10,920 million from ₹8,520 million in Q1 FY26.
Diluted Earnings Per Share (EPS): Stood at ₹40.37 per share for the quarter, compared to ₹30.10 in Q1 FY26.

Segment-Wise Performance Overview

Apollo Hospitals operates through three core divisions:

Healthcare Services (Hospitals): Revenue for the hospital division grew 22% year-on-year to ₹35,670 million from ₹29,350 million in Q1 FY26. Operating bed capacity across the network reached 8,352 beds (excluding AHLL and managed beds) with an average occupancy rate of 70%, compared to 65% in Q1 FY26. EBITDA for the segment stood at ₹8,620 million.

Apollo HealthCo (Digital Health & Pharmacy Distribution): Apollo HealthCo recorded a 20% revenue growth to ₹29,770 million, up from ₹24,720 million in Q1 FY26. EBITDA rose to ₹1,710 million compared to ₹940 million in the prior-year period. Offline pharmacy distribution contributed ₹26,290 million, while the digital platform generated ₹3,480 million. The company added 151 net new stores during the quarter, extending its physical retail footprint to 7,440 stores. Apollo 24/7 achieved a Gross Merchandise Value (GMV) of ₹5,350 million, up 23% year-on-year.

Apollo Health and Lifestyle Limited (AHLL): The retail health and diagnostics unit registered a 15% revenue increase to ₹4,990 million. Diagnostics revenue stood at ₹2,000 million, while specialty centers (Apollo Spectra) generated ₹800 million.

Capacity Expansion and Strategic Restructuring

According to regulatory filings, Apollo Hospitals launched a 180-bed hospital facility in Sarjapur, Bangalore, during Q1 FY27. The group announced plans to add over 5,800 total beds (4,700 census beds) over the next five years through greenfield and brownfield expansions, including new projects in Indore, Dwarka (Delhi), Delhi Proton Centre, and Ranchi.

In addition, the Board approved the appointment of Price Waterhouse Chartered Accountants LLP as the statutory auditor for a five-year term starting from the conclusion of the 46th Annual General Meeting in 2027, succeeding Deloitte Haskins & Sells LLP.

The Board also noted a slump sale transfer by material subsidiary Apollo HealthCo Limited of its FMCG, wellness, and consumer healthcare distribution undertaking to its wholly owned subsidiary, Apollo Consumer Products Limited.

Official Sources Section

Statements, operational metrics, and financial figures in this report are based on official regulatory disclosures submitted by Apollo Hospitals Enterprise Limited to the National Stock Exchange of India and the BSE Limited. Additional strategic details were sourced from company press announcements and statutory filings.

Quote Section

According to official executive statements released alongside the financial results:

"Q1 FY27 marks a strong start to the year, building on the momentum of FY26. Consolidated revenue grew 21% year-on-year to ₹7,043 crore, supported by strong-based performance across Healthcare Services, Diagnostics and Retail Health, and Digital Health and Pharmacy. The performance reflects the strength of our integrated model and the continued trust that patients and their families place in Apollo."
— Dr. Prathap C. Reddy, Founder & Chairman, Apollo Hospitals Group

Why It Matters

Apollo Hospitals' financial beat signals robust demand for private tertiary healthcare, diagnostic testing, and digital pharmacy fulfillment across India. Increased inpatient volumes, higher bed occupancy (70%), and international patient revenue growth of 26% underscore a sustained post-pandemic consolidation in regional healthcare delivery. The planned addition of 5,800 beds indicates sustained capital commitment toward expanding institutional medical infrastructure.

Key Facts at a Glance

Q1 FY27 Net Profit: ₹5.81 billion (+34% YoY).
Q1 FY27 Revenue: ₹70.43 billion (+21% YoY).
Bed Occupancy Rate: Rose to 70% across 8,352 operating beds.
Pharmacy & Digital Network: 7,440 total pharmacy stores following 151 net new store additions in Q1.
5-Year Bed Capacity Expansion Plan: Over 5,800 beds (4,700 census beds) planned across key markets.

Frequently Asked Questions (FAQ)

Q1: What were Apollo Hospitals' main financial highlights for Q1 FY27?

Apollo Hospitals posted a consolidated revenue of ₹70.43 billion and a consolidated net profit of ₹5.81 billion, beating analyst market estimates.

Q2: How did Apollo Hospitals perform compared to analyst expectations?

The company exceeded LSEG IBES projections, reporting ₹70.43 billion in revenue (vs. ₹69.06 billion estimated) and ₹5.81 billion in net profit (vs. ₹5.62 billion estimated).